Lung Cancer and Air Pollution: Understanding Your Environmental Risk

For most of the 20th century, the conversation about lung cancer was dominated by a single word: smoking. And rightly so — tobacco causes approximately 85% of lung cancer cases in the US, and the epidemiological evidence linking smoking to lung cancer is among the strongest in medicine.

But that framing left something important in shadow: the 15% of lung cancers that occur in people who have never smoked. In absolute numbers, that's approximately 30,000 Americans per year — more than the total deaths from cervical cancer, melanoma, or liver cancer. If never-smoker lung cancer were classified as its own disease, it would rank among the ten most lethal cancers in the United States.

What causes lung cancer in people who have never smoked? The answer, increasingly supported by evidence, is predominantly environmental: radon, air pollution (PM2.5 specifically), occupational carcinogens, and secondhand smoke. Of these, outdoor and indoor air pollution has received the most systematic research attention in recent years — and the evidence that IARC classifies outdoor air pollution as a Group 1 lung carcinogen has moved the conversation from "smoking is the lung cancer problem" to "air pollution is the lung cancer problem we haven't been talking about."

Your lifetime air quality history is a cancer risk variable. PollutionProfile's Historical Exposure Recorder makes that history visible for the first time.

Radon is responsible for approximately 21,000 lung cancer deaths in the US annually, making it the second leading cause of lung cancer after smoking and the leading cause among never-smokers.

It is also, remarkably, both highly preventable and dramatically underaddressed.

How radon causes lung cancer Radon is a radioactive gas that decays into radioactive progeny — polonium-218, lead-214, bismuth-214, and polonium-214. These progeny attach to airborne particles and are inhaled, depositing on the bronchial epithelium. The alpha radiation they emit at close range damages DNA in the cells lining the airways — the same cells from which lung cancer arises.

The dose-response relationship The evidence for radon-lung cancer risk comes primarily from studies of underground miners with extremely high occupational radon exposure. Extrapolating that relationship to residential exposure levels is methodologically controversial — the BEIR VI report of 1999 remains the authoritative risk assessment for residential radon. It estimates that at the EPA's action level of 4 pCi/L, lifetime risk is approximately 2.3% for never-smokers and 14.4% for smokers (the combination of radon and tobacco smoke is synergistic).

The testing and mitigation gap The EPA estimates that only about 17% of US homes have been tested for radon. Of those with levels above 4 pCi/L — approximately 1 in 15 US homes — many have not been mitigated. Sub-slab depressurisation — the most common mitigation method — typically reduces radon levels by 90% or more and costs $800–2,500 to install. By any cost-effectiveness metric, radon testing and mitigation is one of the most valuable cancer prevention investments a homeowner can make.

The International Agency for Research on Cancer classified outdoor air pollution — and PM2.5 specifically — as a Group 1 lung carcinogen in 2013, based on sufficient evidence from human epidemiological studies.

The key studies A 2013 meta-analysis published in Environmental Health Perspectives pooled data from 17 cohort studies across North America, Europe, and Australia, totalling over 300,000 participants. For every 10 µg/m³ increase in long-term PM2.5 exposure, lung cancer risk increased by 9% — a modest relative risk but substantial in population terms given the near-universal exposure.

The European ESCAPE study, published the same year, found even larger effects in the European context — a 40% increase in lung cancer risk per 10 µg/m³ increment of PM2.5.

Duration and dose The cancer risk from air pollution, like most carcinogenic exposures, is driven by cumulative lifetime dose — the integral of concentration and time. Someone who spent 30 years in a high-PM2.5 environment before moving to clean air carries a different risk profile than someone who spent the same years in clean air and is now living near a busy road.

This is precisely why a lifetime air quality history — not just today's reading — is the relevant metric for cancer risk. PollutionProfile's Historical Exposure Recorder reconstructs annual mean PM2.5 estimates for every address in your history, generating the cumulative dose estimate that individual snapshots cannot provide.

Translating your lifetime air quality history into a lung cancer risk context requires understanding both what the numbers mean and what they don't.

What your historical air quality data represents For each address in your history, PollutionProfile estimates annual mean PM2.5 based on the nearest monitoring station data and modelled air quality products. The cumulative exposure estimate weights these by years of residence and developmental stage.

Contextualising the risk estimate A risk estimate that your cumulative PM2.5 exposure places you at 1.3 times the population average for air pollution-related lung cancer risk means: • If the population baseline lung cancer mortality rate is approximately 45 per 100,000 per year • Your estimated rate from this exposure category is approximately 58 per 100,000 per year • This is not a prediction — individual genetic susceptibility, smoking history, radon exposure, and other factors all modify actual risk substantially

The actionable conversation with your physician: If you have a significant lifetime PM2.5 exposure history — decades in a high-pollution urban environment, residence near industrial facilities, or occupational PM2.5 exposure — the conversation to have with your doctor is about whether you qualify for lung cancer screening.

The current US Preventive Services Task Force recommendation covers annual low-dose CT screening for adults aged 50–80 who have a 20-pack-year smoking history and currently smoke or quit within the past 15 years. Air pollution history is not yet incorporated into formal screening criteria — but several oncology centres are developing risk models that include environmental exposure. Your PollutionProfile air quality history provides the data for that conversation.